Skip to main content
Erschienen in: Drugs & Aging 1/2016

01.01.2016 | Short Communication

Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia

verfasst von: Amanda J. Cross, Johnson George, Michael C. Woodward, David Ames, Henry Brodaty, Jenni Ilomäki, Rohan A. Elliott

Erschienen in: Drugs & Aging | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

There has been limited research into potentially inappropriate medication (PIM) use and anticholinergic burden in patients attending memory clinics.

Objectives

The aim of this study was to explore the use of PIMs related to cognitive impairment (PIMcog), anticholinergic cognitive burden (ACB) and concomitant use of anticholinergic medications with cholinesterase inhibitors (ChEIs) in patients attending memory clinics.

Methods

Cross-sectional analysis of baseline data from the Prospective Research In MEmory clinics (PRIME) study was performed. Participants were community-dwelling patients who attended nine memory clinics and had a diagnosis of mild cognitive impairment or dementia. PIMcog were defined as any medication considered potentially inappropriate for patients with cognitive impairment according to the Beers or STOPP criteria. Clinically significant ACB was defined as total score of ≥3 on the ACB scale.

Results

A total of 964 patients, mean age 77.6 years, were included. PIMcog were used by 206 (21.4 %) patients. Anticholinergics and sedatives were the most common PIMcog. PIMcog use was associated with higher number of medications (adjusted OR 1.26; 95 % CI 1.19–1.33) and with not having completed secondary level education (adjusted OR 1.71; 95 % CI 1.01–2.89). One hundred and thirteen (11.7 %) patients had a clinically significant ACB score (≥3). ChEIs were used by 575 patients and 65 (11.3 %) of these had an ACB score ≥3. There was no statistically significant difference in ChEI use between patients with and without an ACB score ≥3.

Conclusion

PIMcog use, clinically significant anticholinergic burden, and concurrent use of anticholinergics with ChEIs were prevalent in patients attending memory clinics. Efforts are needed to improve prescribing for people with cognitive impairment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lau DT, Mercaldo ND, Shega JW, et al. Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. Am J Alzheimers Dis Other Demen. 2011;26:606–15.PubMedPubMedCentralCrossRef Lau DT, Mercaldo ND, Shega JW, et al. Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. Am J Alzheimers Dis Other Demen. 2011;26:606–15.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Akazawa M, Imai H, Igarashi A, et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010;8:146–60.PubMedCrossRef Akazawa M, Imai H, Igarashi A, et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010;8:146–60.PubMedCrossRef
3.
Zurück zum Zitat Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31:42–51.PubMedPubMedCentralCrossRef Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31:42–51.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43:1171–6.PubMedCrossRef Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43:1171–6.PubMedCrossRef
5.
Zurück zum Zitat American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.
6.
Zurück zum Zitat O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.PubMedPubMedCentralCrossRef O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477–83.PubMedCrossRef Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477–83.PubMedCrossRef
8.
Zurück zum Zitat Sittironnarit G, Ames D, Bush AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord. 2011;31:173–8.PubMedCrossRef Sittironnarit G, Ames D, Bush AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord. 2011;31:173–8.PubMedCrossRef
9.
Zurück zum Zitat Sink KM, Thomas J 3rd, Xu H, et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc. 2008;56:847–53.PubMedPubMedCentralCrossRef Sink KM, Thomas J 3rd, Xu H, et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc. 2008;56:847–53.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef
11.
Zurück zum Zitat Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63:85–90.PubMedCrossRef Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63:85–90.PubMedCrossRef
12.
Zurück zum Zitat Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30:103–12.PubMedCrossRef Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30:103–12.PubMedCrossRef
13.
Zurück zum Zitat Barton C, Sklenicka J, Sayegh P, et al. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother. 2008;6:147–52.PubMedCrossRef Barton C, Sklenicka J, Sayegh P, et al. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother. 2008;6:147–52.PubMedCrossRef
14.
Zurück zum Zitat Woodward MC, Woodward E. A national survey of memory clinics in Australia. Int Psychogeriatr. 2009;21:696–702.PubMedCrossRef Woodward MC, Woodward E. A national survey of memory clinics in Australia. Int Psychogeriatr. 2009;21:696–702.PubMedCrossRef
15.
Zurück zum Zitat American Psyciatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psyciatric Association; 2000. American Psyciatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psyciatric Association; 2000.
16.
Zurück zum Zitat Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.PubMedCrossRef Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.PubMedCrossRef
17.
Zurück zum Zitat Brodaty H, Woodward M, Boundy K, et al. Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months. Int Psychogeriatr. 2011;23:1086–96.PubMedCrossRef Brodaty H, Woodward M, Boundy K, et al. Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months. Int Psychogeriatr. 2011;23:1086–96.PubMedCrossRef
18.
Zurück zum Zitat Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
19.
Zurück zum Zitat Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725–9.PubMedCrossRef Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725–9.PubMedCrossRef
20.
Zurück zum Zitat World Health Organization Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical classifications system with defined daily doses (ATC/DDD) index. World Health Organization Collaborating Centre for Drug Statistics Methodology [cited 2015 March]; http://www.whocc.no/atc_ddd_index/. World Health Organization Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical classifications system with defined daily doses (ATC/DDD) index. World Health Organization Collaborating Centre for Drug Statistics Methodology [cited 2015 March]; http://​www.​whocc.​no/​atc_​ddd_​index/​.
21.
Zurück zum Zitat Hubbard RE, Peel NM, Scott IA, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202:373–7.PubMedCrossRef Hubbard RE, Peel NM, Scott IA, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202:373–7.PubMedCrossRef
22.
Zurück zum Zitat Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225–33.PubMedPubMedCentral Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225–33.PubMedPubMedCentral
23.
Zurück zum Zitat Campbell NL, Maidment I, Fox C, et al. The 2012 Update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61(Suppl. 1):S142–3. Campbell NL, Maidment I, Fox C, et al. The 2012 Update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61(Suppl. 1):S142–3.
24.
Zurück zum Zitat Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine Use. Curr Pharm Des. 2002;8:45–58.PubMedCrossRef Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine Use. Curr Pharm Des. 2002;8:45–58.PubMedCrossRef
25.
Zurück zum Zitat Lau DT, Mercaldo ND, Harris AT, et al. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24:56–63.PubMedPubMedCentralCrossRef Lau DT, Mercaldo ND, Harris AT, et al. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24:56–63.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Weston AL, Weinstein AM, Barton C, et al. Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci. 2010;65:318–21.PubMedCrossRef Weston AL, Weinstein AM, Barton C, et al. Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci. 2010;65:318–21.PubMedCrossRef
27.
Zurück zum Zitat Campbell N, Perkins A, Hui S, et al. Association between prescribing of anticholinergic medications and incident delirium: a cohort study. J Am Geriatr Soc. 2011;59(Suppl 2):S277–81.PubMedPubMedCentralCrossRef Campbell N, Perkins A, Hui S, et al. Association between prescribing of anticholinergic medications and incident delirium: a cohort study. J Am Geriatr Soc. 2011;59(Suppl 2):S277–81.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat He Z, Ball PA. Can medication management review reduce anticholinergic burden (ACB) in the elderly? Encouraging results from a theoretical model. Int Psychogeriatr. 2013;25:1425–31.PubMedCrossRef He Z, Ball PA. Can medication management review reduce anticholinergic burden (ACB) in the elderly? Encouraging results from a theoretical model. Int Psychogeriatr. 2013;25:1425–31.PubMedCrossRef
29.
Zurück zum Zitat Haider SI, Johnell K, Weitoft GR, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57:62–9.PubMedCrossRef Haider SI, Johnell K, Weitoft GR, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57:62–9.PubMedCrossRef
30.
Zurück zum Zitat Montastruc F, Gardette V, Cantet C, et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol. 2013;69:1589–97.PubMedCrossRef Montastruc F, Gardette V, Cantet C, et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol. 2013;69:1589–97.PubMedCrossRef
31.
Zurück zum Zitat Carnahan RM, Lund BC, Perry PJ, et al. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004;52:2082–7.PubMedCrossRef Carnahan RM, Lund BC, Perry PJ, et al. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004;52:2082–7.PubMedCrossRef
32.
Zurück zum Zitat Nishtala PS, Mclachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry. 2008;16:621–32.PubMedCrossRef Nishtala PS, Mclachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry. 2008;16:621–32.PubMedCrossRef
33.
Zurück zum Zitat Ni Chroinin D, Ni Chroinin C, Beveridge A. Factors influencing deprescribing habits among geriatricians. Age Ageing. 2015;44:704–8.PubMedCrossRef Ni Chroinin D, Ni Chroinin C, Beveridge A. Factors influencing deprescribing habits among geriatricians. Age Ageing. 2015;44:704–8.PubMedCrossRef
34.
Zurück zum Zitat Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85:86–8.PubMedCrossRef Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85:86–8.PubMedCrossRef
35.
Zurück zum Zitat Jyrkka J, Enlund H, Lavikainen P, et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011;20:514–22.PubMedCrossRef Jyrkka J, Enlund H, Lavikainen P, et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011;20:514–22.PubMedCrossRef
36.
Zurück zum Zitat Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing. 2005;34:626–32.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing. 2005;34:626–32.PubMedCrossRef
37.
Zurück zum Zitat Peterson JF, Kripalani S, Danciu I, et al. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc. 2014;62:2148–52.PubMedPubMedCentralCrossRef Peterson JF, Kripalani S, Danciu I, et al. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc. 2014;62:2148–52.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 2014;4:e006544. doi:10.1136/bmjopen-2014-006544 Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 2014;4:e006544. doi:10.​1136/​bmjopen-2014-006544
39.
Zurück zum Zitat Elliott RA, Woodward MC. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital. Aust J Ageing. 2011;30:124–9.CrossRef Elliott RA, Woodward MC. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital. Aust J Ageing. 2011;30:124–9.CrossRef
40.
Zurück zum Zitat Rojas-Fernandez CH, Patel T, Lee L. An interdisciplinary memory clinic: a novel practice setting for pharmacists in primary care. Ann Pharmacother. 2014;48:785–95.PubMedCrossRef Rojas-Fernandez CH, Patel T, Lee L. An interdisciplinary memory clinic: a novel practice setting for pharmacists in primary care. Ann Pharmacother. 2014;48:785–95.PubMedCrossRef
41.
Zurück zum Zitat Bregnhoj L, Thirstrup S, Kristensen MB, et al. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol. 2009;65:199–207.PubMedCrossRef Bregnhoj L, Thirstrup S, Kristensen MB, et al. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol. 2009;65:199–207.PubMedCrossRef
42.
Zurück zum Zitat Nahin RL, Pecha M, Welmerink DB, et al. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009;57:1197–205.PubMedCrossRef Nahin RL, Pecha M, Welmerink DB, et al. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009;57:1197–205.PubMedCrossRef
43.
Zurück zum Zitat Bosboom PR, Alfonso H, Almeida OP, et al. Use of potentially harmful medications and health-related quality of life among people with dementia living in residential aged care facilities. Dement Geriatr Cogn Dis Extra. 2012;2:361–71.PubMedPubMedCentralCrossRef Bosboom PR, Alfonso H, Almeida OP, et al. Use of potentially harmful medications and health-related quality of life among people with dementia living in residential aged care facilities. Dement Geriatr Cogn Dis Extra. 2012;2:361–71.PubMedPubMedCentralCrossRef
Metadaten
Titel
Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia
verfasst von
Amanda J. Cross
Johnson George
Michael C. Woodward
David Ames
Henry Brodaty
Jenni Ilomäki
Rohan A. Elliott
Publikationsdatum
01.01.2016
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 1/2016
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-015-0332-3

Weitere Artikel der Ausgabe 1/2016

Drugs & Aging 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.